[Express Train - Episode 49] Hankook McNulty, From Green Coffee Beans to Roasted Coffee Products

Korea McNulty is engaged in coffee-related businesses ranging from green coffee beans to roasted coffee products. Their products are broadly categorized into four types: green beans, roasted coffee, instant coffee, and coffee beverages. They purchase active pharmaceutical ingredients and manufacture finished pharmaceutical products in forms consumable by consumers.

Korea McNulty's ultra-low temperature micro-grinding technology utilizes cryogenic processing below minus 196 degrees Celsius to grind coffee at the micrometer scale. This technology allows for easy consumption of nutrients as they are and maximizes absorption within the body.

The pharmaceutical division researches and develops products that are difficult for conventional pharmaceutical companies to produce or require advanced formulation technologies. From the early stages of the business, they established a pharmaceutical formulation research institute and invested in research personnel and equipment. They hired dedicated researchers and actively invested in formulation equipment, building research equipment that is difficult for small and medium-sized pharmaceutical companies to possess. They were the first in Korea to produce the triple-coated pellet formulation cold medicine Senticol Capsule and have supplied it since 2007 to companies such as Green Cross, Samjin Pharmaceutical, Koryo Pharmaceutical, and Binex. This division accounts for 23.3% of total sales.

Patent attorney Eom Jeong-han from BLT Patent Law Firm reviewed Korea McNulty’s patent and trademark application status.

Listed companies on the domestic stock market disclose patent acquisition information through the Financial Supervisory Service’s electronic disclosure system. However, many stock investors tend to overlook patent disclosures.

Patents and trademark registrations are important indicators for understanding future corporate value because they signal the direction a listed company is heading. Some patent disclosures even act as direct triggers for stock price increases.

It is not easy for general investors to assess the impact of patent disclosures on companies or to check trademark application statuses one by one. Asia Economy, together with patent attorney Eom Jeong-han from BLT Patent Law Firm, is reviewing the patent and trademark application statuses of listed companies through the 'Express Train' program.

'Express Train' is an abbreviation for a broadcast that diligently searches for stocks surging due to patents.